NASDAQ:SXTP

60 Degrees Pharma Nears FDA Deadline in Thin Holiday Trading
····

60 Degrees Pharma Nears FDA Deadline in Thin Holiday Trading

60 Degrees Pharmaceuticals (SXTP) closed unchanged at $1.48 Tuesday as investors awaited an FDA decision deadline on its Australian Chestnut Extract NDIN. The stock rose 6.5% last week but remains thinly traded. First-quarter net product revenue fell to $162,000, with a net loss of $2.21 million. Eric Francois joined the board on May 13, according to a May 18 filing.
May 25, 2026

Stock Market Today

  • Approach to ASX Shares Amid Market Uncertainty
    May 28, 2026, 8:15 PM EDT. This disclaimer highlights that Kalkine Media provides educational content without offering investment advice or recommendations. Investors are urged to seek guidance from qualified professionals such as financial advisers or stockbrokers before making decisions on ASX shares. Kalkine Media disclaims liability for any losses stemming from use of its content, emphasizing that the material should not be considered a solicitation to buy or sell securities amidst uncertain market conditions.